MyTomorrows

MyTomorrows is a global health technology company that provides patients with life-threatening or severe chronic diseases, and their doctors, access to treatments in development. The company was founded in 2012 by Ronald Brus, a former CEO of Crucell. MyTomorrows provides information about treatment options in development, assists with requests for access to these treatments, and manages the entire process of receiving the treatment.

History

MyTomorrows was founded in 2012 by Ronald Brus, a former CEO of Crucell. The company was established with the aim of providing patients with life-threatening or severe chronic diseases, and their doctors, access to treatments in development.

Services

MyTomorrows provides information about treatment options in development, assists with requests for access to these treatments, and manages the entire process of receiving the treatment. The company works with pharmaceutical and biotech companies to provide access to their drugs in development.

Criticism

Despite its noble intentions, MyTomorrows has faced criticism. Some critics argue that the company is exploiting desperate patients and their families, while others question the ethics of providing access to unapproved treatments.

See also

• Clinical trial
• Compassionate use
• Experimental drug

External links

• Official website

MyTomorrows Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski